Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Pozycja w akcjach #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Cena akcji
$1.50
Ostatnia synchronizacja: 2026-09-21
Kapitalizacja rynkowa
$3.63M
Zmiana (1 dzień)
-4.46%
Zmiana (1 rok)
-72.68%
Kraj
MY
Handel BioNexus Gene Lab Corp. (BGLC)

Kategoria

Zyski dla BioNexus Gene Lab Corp. (BGLC)
Zyski w Jun 2026 TTM: $-2.58M
Według najnowszych raportów finansowych BioNexus Gene Lab Corp., obecny zysk firmy wynosi $-2.58M. W roku 2023 firma osiągnęła zysk w wysokości $-2.61M, spadek w porównaniu do zysku z roku 2022, który wynosił $-303.66K. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy BioNexus Gene Lab Corp. od 2016 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-2.58M 61.47%
2024 $-1.59M -38.84%
2023 $-2.61M 758.71%
2022 $-303.66K -129.12%
2021 $1.04M -17.40%
2020 $1.26M -557.92%
2019 $-275.71K -560.27%
2018 $59.90K -150.16%
2017 $-119.41K 14,201.08%
2016 $-835.00 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$2.69B -104,366.42%
US
$1.78B -69,051.75%
US
- -
US
$934.20M -36,377.72%
US
- -
US